CD
Cardax, Inc.
CDXI · OTC
$0.00 +0.00% (+$0.00)
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
3/9Valuation
-
N/A P/E N/A
EV/EBITDA N/A
P/S N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
-
N/A ROIC N/A
ROE N/A
ROA N/A
Debt
-
N/A Debt/Equity N/A
Current ratio N/A
Int. coverage N/A
Stability
33 /100
Unstable Beta -2.98x
Profitable years 0
Rev. volatility N/A
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about CDXI
Online
Sector
Healthcare
Industry
Biotechnology
CEO
David G. Watumull
Employees
10
Headquarters
Honolulu